Amanda G. Paulovich

Oncology
825 Eastlake Ave E
Seattle, WA 98109

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 72 publications

Longitudinal Detection of Tumor-Specific Peptides in Cerebrospinal Fluid for Pediatric Brain Tumor Surveillance.

Longitudinal Detection of Tumor-Specific Peptides in Cerebrospinal Fluid for Pediatric Brain Tumor Surveillance.

Journal: Cells
Published: January 14, 2026

Loss of the USP22 deubiquitylase confers resistance to chemotherapy in small cell lung cancer.

Loss of the USP22 deubiquitylase confers resistance to chemotherapy in small cell lung cancer.

Journal: Nature communications
Published: April 09, 2025

The DNA-PK inhibitor AZD7648 alone or combined with pegylated liposomal doxorubicin in patients with advanced cancer: results of a first-in-human Phase I/IIa study.

The DNA-PK inhibitor AZD7648 alone or combined with pegylated liposomal doxorubicin in patients with advanced cancer: results of a first-in-human Phase I/IIa study.

Journal: British journal of cancer
Published: November 04, 2024

Proteogenomic characterization of highly enriched viable leukemic blasts in acute myeloid leukemia: A SWOG report.

Proteogenomic characterization of highly enriched viable leukemic blasts in acute myeloid leukemia: A SWOG report.

Journal: EJHaem
Published: September 09, 2024

Targeted Mass Spectrometry for Quantification of Receptor Tyrosine Kinase Signaling.

Targeted Mass Spectrometry for Quantification of Receptor Tyrosine Kinase Signaling.

Journal: Methods in molecular biology (Clifton, N.J.)
Published: July 25, 2024

Neoadjuvant vidutolimod and nivolumab in high-risk resectable melanoma: A prospective phase II trial.

Neoadjuvant vidutolimod and nivolumab in high-risk resectable melanoma: A prospective phase II trial.

Journal: Cancer cell
Published: June 13, 2024

Proteogenomic analysis of chemo-refractory high-grade serous ovarian cancer.

Proteogenomic analysis of chemo-refractory high-grade serous ovarian cancer.

Journal: Cell
Published: February 16, 2024

Characterization of an expanded set of assays for immunomodulatory proteins using targeted mass spectrometry.

Characterization of an expanded set of assays for immunomodulatory proteins using targeted mass spectrometry.

Journal: Scientific data
Published: February 01, 2024

RNA and phosphoprotein profiles of TP53- and PTEN-knockouts in MCF10A at baseline and responding to DNA damage.

RNA and phosphoprotein profiles of TP53- and PTEN-knockouts in MCF10A at baseline and responding to DNA damage.

Journal: Scientific data
Published: July 25, 2023

Pan-cancer proteogenomics characterization of tumor immunity.

Pan-cancer proteogenomics characterization of tumor immunity.

Journal: Cell
Published: April 26, 2023

Monitoring Both Extended and Tryptic Forms of Stable Isotope-Labeled Standard Peptides Provides an Internal Quality Control of Proteolytic Digestion in Targeted Mass Spectrometry-Based Assays.

Monitoring Both Extended and Tryptic Forms of Stable Isotope-Labeled Standard Peptides Provides an Internal Quality Control of Proteolytic Digestion in Targeted Mass Spectrometry-Based Assays.

Journal: Molecular & cellular proteomics : MCP
Published: April 20, 2023

Tissue Mass Spectrometry: How Solid Is Our Future?

Tissue Mass Spectrometry: How Solid Is Our Future?

Journal: Clinical chemistry
Published: April 01, 2023
Showing 1-12 of 72

Last Updated: 09/26/2026